Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,516
NCT00111826
SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2003
Completion: Dec 31, 2005
NCT00111969
ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy
Start: Jun 30, 2003
Completion: Nov 30, 2005